Tau and apolipoprotein E modulate cerebrovascular tight junction integrity independent of cerebral amyloid angiopathy in Alzheimer’s disease

Cerebrovascular pathologies including cerebral amyloid angiopathy (CAA) and blood‐brain barrier (BBB) dysregulation are prominent features in the majority of Alzheimer's disease (AD) cases.

• Publication year

  2020

• Venue

  Alzheimer's & Dementia

• Publication date

  2020-08-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/alz.12104PMID 32827351PMCID 8103951
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blood-Brain Barrier Leakage and Microvascular Lesions in Cerebral Amyloid Angiopathy

  2019cited by this paper
• Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules

  2019cited by this paper
• Cerebrovascular Smooth Muscle Cells as the Drivers of Intramural Periarterial Drainage of the Brain

  2019cited by this paper
• Prognostic relevance of cortical superficial siderosis in cerebral amyloid angiopathy

  2019cited by this paper
• Ethnoracial differences in Alzheimer’s disease from the FLorida Autopsied Multi-Ethnic (FLAME) cohort

  2019cited by this paper
• 2019 Alzheimer's disease facts and figures

  2019cited by this paper
• PECAM-1 Stabilizes Blood-Brain Barrier Integrity and Favors Paracellular T-Cell Diapedesis Across the Blood-Brain Barrier During Neuroinflammation

  2019cited by this paper
• Blood-brain barrier impairment and hypoperfusion are linked in cerebral small vessel disease

  2019cited by this paper
• Vascular Risk and β‐Amyloid Are Synergistically Associated with Cortical Tau

  2019cited by this paper
• Selective loss of cortical endothelial tight junction proteins during Alzheimer’s disease progression

  2019cited by this paper
• Vascular dysfunction—The disregarded partner of Alzheimer's disease

  2019cited by this paper
• Apoε4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function

  2018cited by this paper
• Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging

  2018cited by this paper
• Vascular cognitive impairment

  2018cited by this paper
• Vascular cognitive impairment

  2018cited by this paper
• Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

  2018cited by this paper
• Capillary cerebral amyloid angiopathy in Alzheimer’s disease: association with allocortical/hippocampal microinfarcts and cognitive decline

  2018cited by this paper
• APOE ε2 is associated with increased tau pathology in primary tauopathy

  2018cited by this paper
• ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy

  2017cited by this paper
• APOE &egr;4/&egr;4 diminishes neurotrophic function of human iPSC-derived astrocytes

  2017cited by this paper
• Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer’s Disease

  2017cited by this paper
• Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study

  2017cited by this paper
• Blood–Brain Barrier Dysfunction as a Hallmark Pathology in Chronic Traumatic Encephalopathy

  2016cited by this paper
• Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer’s disease-related microvascular cerebral amyloid angiopathy

  2016cited by this paper
• Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer’s disease

  2016cited by this paper
• A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

  2016cited by this paper
• 2016 Alzheimer's disease facts and figures

  2016cited by this paper
• Human Apolipoprotein E ε4 Expression Impairs Cerebral Vascularization and Blood—Brain Barrier Function in Mice

  2015cited by this paper
• Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy

  2015cited by this paper
• Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly

  2015cited by this paper
• Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum

  2015cited by this paper
• The blood-brain barrier.

  2015cited by this paper
• Effects of vascular risk factors and APOE ε4 on white matter integrity and cognitive decline

  2015cited by this paper
• Failure of Perivascular Drainage of β‐amyloid in Cerebral Amyloid Angiopathy

  2014cited by this paper
• The role of claudin-5 in blood-brain barrier (BBB) and brain metastases (review).

  2014cited by this paper
• Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging.

  2013cited by this paper
• Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

  2013cited by this paper
• Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre.

  2013cited by this paper
• The blood–brain barrier in health and disease

  2012cited by this paper
• Apolipoprotein E controls cerebrovascular integrity via cyclophilin A

  2012cited by this paper
• White Matter Lesions and Vascular Cognitive Impairment

  2012cited by this paper
• 2011 Alzheimer's disease facts and figures

  2011cited by this paper
• Correlation analysis of capillary APOE, VEGF and eNOS expression in Alzheimer brains.

  2011cited by this paper
• VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown

  2009cited by this paper
• Blood-brain barrier: ageing and microvascular disease--systematic review and meta-analysis.

  2009cited by this paper
• Blood-brain barrier tight junction permeability and ischemic stroke.

  2008cited by this paper
• The blood-brain barrier in health and chronic neurodegenerative disorders.

  2008cited by this paper
• Decreased blood–brain barrier P-glycoprotein function in the progression of Parkinson’s disease, PSP and MSA

  2008cited by this paper
• Mixed brain pathologies account for most dementia cases in community-dwelling older persons

  2007cited by this paper
• PECAM‐1, a key player in neuroinflammation

  2006cited by this paper
• Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms

  2005cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Pathogenesis of cerebral amyloid angiopathy.

  2003cited by this paper
• Cerebral Amyloid Angiopathies: A Pathologic, Biochemical, and Genetic View

  2003cited by this paper
• Vascular Pathology in Alzheimer Disease: Correlation of Cerebral Amyloid Angiopathy and Arteriosclerosis/Lipohyalinosis with Cognitive Decline

  2003cited by this paper
• Cerebrovascular Effects of Amyloid-ß Peptides: Mechanisms and Implications for Alzheimer's Dementia

  2003cited by this paper
• Alzheimer Disease as a Vascular Disorder: Nosological Evidence

  2002cited by this paper
• Phases of Aβ-deposition in the human brain and its relevance for the development of AD

  2002cited by this paper
• Molecular physiology and pathophysiology of tight junctions in the blood–brain barrier

  2001cited by this paper
• Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease

  1996cited by this paper
• Cerebral amyloid angiopathy. A critical review.

  1987cited by this paper

• Integrative epigenomic landscape of Alzheimer’s Disease brains reveals oligodendrocyte molecular perturbations associated with tau

  2026influential citation
• Biomarkers of blood–brain barrier and neurovascular unit integrity in human cognitive impairment and dementia

  2025cites this paper
• Cerebrovascular disease in Alzheimer's disease: Brain structure as a critical mediator of cognitive decline

  2025cites this paper
• Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration

  2025cites this paper
• A study on the effect of blue light on kidney stone formation in rats via the brain-kidney axis

  2025cites this paper
• Protection of Alzheimer’s disease progression by a human-origin probiotics cocktail

  2025cites this paper
• Pathological angiogenesis was associated with cerebrovascular lesion and neurodegeneration in Alzheimer's disease

  2025cites this paper
• Association of blood-based neurodegenerative biomarkers with cognitive functioning and dementia in India (LASI-DAD) and the United States (HRS)

  2025cites this paper
• Pathomechanism of postoperative delirium: Systemic inflammatory response and neuroinflammation following anesthesia/surgery.

  2025cites this paper
• Blood-brain barrier impairment as an early marker of neurodegeneration in late-onset epilepsy of unknown origin.

  2025cites this paper
• The vascular contribution of apolipoprotein E to Alzheimer's disease.

  2024cites this paper
• The UFMylation pathway is impaired in Alzheimer’s disease

  2024cites this paper
• APOE 𝜀4‐related blood–brain barrier breakdown is associated with microstructural abnormalities

  2024cites this paper
• Single-Nucleus Landscape of Glial Cells and Neurons in Alzheimer’s Disease

  2024influential citation
• Effect of Apolipoprotein E isoforms on the Abundance and Function of P-glycoprotein in Human Brain Microvascular Endothelial Cells

  2024cites this paper
• Challenges and Future Perspectives in Modeling Neurodegenerative Diseases Using Organ‐on‐a‐Chip Technology

  2024cites this paper
• Neuropathogenesis-on-chips for neurodegenerative diseases

  2024cites this paper
• The UFMylation pathway is impaired in Alzheimer’s disease

  2024cites this paper
• QKL injection ameliorates Alzheimer's disease-like pathology by regulating expression of RAGE.

  2024cites this paper
• Early- and Late-Onset Alzheimer’s Disease: Two Sides of the Same Coin?

  2024cites this paper
• Cellular junction dynamics and Alzheimer’s disease: a comprehensive review

  2024cites this paper
• Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer’s disease

  2024cites this paper
• Decreased microvascular claudin‐5 levels in cerebral amyloid angiopathy associated with intracerebral haemorrhage

  2024cites this paper
• Intermittent fasting and Alzheimer's disease—Targeting ketone bodies as a potential strategy for brain energy rescue

  2023influential citation
• Role of Enlarged Perivascular Space in the Temporal Lobe in Cerebral Amyloidosis

  2023influential citation
• Relationship of APOE with Alzheimer's Disease and Other Neurological Disorders: An Updated Review.

  2023cites this paper
• Blood-Brain Barrier Dysfunction in Normal Aging and Neurodegeneration: Mechanisms, Impact, and Treatments

  2023cites this paper
• Engineered nanomaterials that exploit blood-brain barrier dysfunction fordelivery to the brain.

  2023cites this paper
• Upregulation of sFRP1 Is More Profound in Female than Male 5xFAD Mice and Positively Associated with Amyloid Pathology

  2023cites this paper
• Increased tau expression in the APOE4 blood-brain barrier model is associated with reduced anti-tau therapeutic antibody delivery in vitro

  2023cites this paper
• Research Progress on Natural Plant Molecules in Regulating the Blood–Brain Barrier in Alzheimer’s Disease

  2023cites this paper
• Rebuilding insight into the pathophysiology of Alzheimer's disease through new blood-brain barrier models

  2023cites this paper
• The Role of Immunity in Alzheimer's Disease

  2022cites this paper
• Small molecule compound K-7174 attenuates neuropsychiatric manifestations in lupus-prone mice.

  2022cites this paper
• ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies

  2022cites this paper
• Peripheral apoE4 enhances Alzheimer’s pathology and impairs cognition by compromising cerebrovascular function

  2022cites this paper
• Targetability of the neurovascular unit in inflammatory diseases of the central nervous system

  2022cites this paper
• APOE deficiency impacts neural differentiation and cholesterol biosynthesis in human iPSC-derived cerebral organoids

  2022cites this paper
• Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s disease related proteins

  2022cites this paper
• APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer’s disease with Lewy body pathology

  2022influential citation
• Addressing Blood–Brain Barrier Impairment in Alzheimer’s Disease

  2022cites this paper
• Blood-Brain Barrier Disruption: A Common Driver of Central Nervous System Diseases

  2021cites this paper
• The region‐selective regulation of endothelial claudin‐5 expression and signaling in brain health and disorders

  2021cites this paper
• T hisisthepeerreview edversionofthefollow ingarticle: Blood-BrainBarrierDisruption:A Com m onDriverofCentralN ervousS ystem

  2021cites this paper
• Normal cerebrospinal fluid concentrations of PDGFRβ in patients with cerebral amyloid angiopathy and Alzheimer's disease

  2021cites this paper
• APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia

  2021cites this paper
• Tau Pathologies Mediate the Associations of Vascular Risk Burden with Cognitive Impairments in Non-demented Elders: The CABLE Study

  2021cites this paper
• Apolipoprotein E regulates lipid metabolism and α-synuclein pathology in human iPSC-derived cerebral organoids

  2021cites this paper
• Blood–Brain Barrier and Neurodegenerative Diseases—Modeling with iPSC-Derived Brain Cells

  2021cites this paper
• Brain Barriers and brain fluids research in 2020 and the fluids and barriers of the CNS thematic series on advances in in vitro modeling of the bloodbrain barrier and neurovascular unit

  2021cites this paper
• Comparative Analysis of Multiple Neurodegenerative Diseases Based on Advanced Epigenetic Aging Brain

  2021cites this paper
• Cognitive impact of COVID-19: looking beyond the short term

  2020cites this paper
• Leaky pipes: Tau and apoE implicated in blood-brain barrier dysfunction in Alzheimer disease

  2020cites this paper